Form C-AR — RS BioTherapeutics Inc.
0001932193-26-000004 · filed Sep 23, 2026
https://rsbiotherapeutics.com
(possible website — auto-inferred, not verified)
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 1932193
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 157 BALTIMORE ST. SUITE 140
CUMBERLAND, MD 21502 - Phone
- —
Most recent fiscal year financials
- Total assets
- $13,807
- Cash
- —
- Short-term debt
- $1,249,122
- Long-term debt
- $188,555
- Revenues
- $1,778
- COGS
- —
- Taxes paid
- —
- Net income
- $-204,030
View the original filing on SEC EDGAR ↗